|
|
Volumn 11, Issue 2, 1998, Pages 158-164
|
|
Individualized strategies in the era of combination antiretroviral therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ASTEMIZOLE;
BENZODIAZEPINE DERIVATIVE;
CD4 ANTIGEN;
CISAPRIDE;
DELAVIRDINE;
DIDANOSINE;
FORTAVASE;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
NUCLEOSIDE DERIVATIVE;
PROTEINASE INHIBITOR;
RIFAMPICIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TERFENADINE;
UNCLASSIFIED DRUG;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
ANEMIA;
ARTICLE;
DRUG COST;
DRUG METABOLISM;
GASTROINTESTINAL TOXICITY;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERBILIRUBINEMIA;
LYMPHOCYTE COUNT;
MOUTH ULCER;
NEPHROLITHIASIS;
NEUTROPENIA;
PANCREATITIS;
PATIENT COMPLIANCE;
PERIPHERAL NEUROPATHY;
PRACTICE GUIDELINE;
RASH;
|
|
EID: 0031892459
PISSN: 08938652
EISSN: None
Source Type: Journal
DOI: 10.3122/15572625-11-2-158 Document Type: Article |
|
Times cited : (2)
|
|
References (2)
|
